Loading…
Coral Laboratories (BSE 524506)₹533.50+3.60%Pharmaceuticals
Coral Laboratories is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 11.6 against a peer median of 14.7, and ROCE of 11.1% against a peer median of 11.0%, and latest-quarter sales growth of −5.8% against a peer median of 17.4%. By market cap it is #8 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accretion Pharmaceuticals | 225 | 23.3 | 28.9 | 27.6 | 0.23 | 0.0 | 89 | 10 | 18.2 | 13.9 | vs BSE 524506 |
| Gennex Laboratories | 218 | 11.2 | 11.0 | 9.2 | 0.36 | 0.0 | 173 | 21 | 16.5 | −6.8 | vs BSE 524506 |
| Sanjivani Paranteral | 214 | 28.8 | 18.0 | 15.6 | 0.30 | 0.3 | 69 | 7 | 33.3 | 44.2 | vs BSE 524506 |
| Kerala Ayurveda | 212 | — | −10.0 | −161.1 | 7.83 | 0.0 | 131 | −16 | 15.9 | −500.5 | vs BSE 524506 |
| Nectar Lifesciences | 198 | — | 0.0 | −31.3 | 0.00 | 0.0 | 0 | −293 | −100.0 | — | vs BSE 524506 |
| Achyut Healthcare | 195 | — | 1.2 | 1.0 | 0.01 | — | 12 | 0 | 381.3 | −46.2 | vs BSE 524506 |
| Brooks Laboratories | 194 | 14.7 | 21.1 | 22.1 | 0.07 | 0.0 | 86 | 25 | −10.0 | −118.6 | vs BSE 524506 |
| Coral Laboratories | 192 | 11.6 | 11.1 | 7.9 | 0.02 | 0.3 | 86 | 16 | −5.8 | 84.8 | — |
| Bio Medica Laboratories | 186 | 11.3 | 27.3 | 45.1 | 1.52 | 0.0 | 43 | 12 | — | — | vs BSE 524506 |
| Oxygenta Pharmaceutical | 185 | — | −34.0 | — | — | 0.0 | 113 | −18 | 144.6 | — | vs BSE 524506 |
| Smruthi Organics | 184 | 25.1 | 8.0 | 5.2 | 0.11 | 0.9 | 102 | 3 | 55.5 | — | vs BSE 524506 |
| Peer median | 195 | 14.7 | 11.0 | 8.6 | 0.17 | 0.0 | 86 | 7 | 17.4 | −6.8 |
Listed companies closest to Coral Laboratories in Pharmaceuticals include Accretion Pharmaceuticals, Gennex Laboratories, Sanjivani Paranteral, Kerala Ayurveda, Nectar Lifesciences, Achyut Healthcare, Brooks Laboratories, Bio Medica Laboratories.
Accretion Pharmaceuticals, with a market cap of ₹225 Cr.
Coral Laboratories trades at a P/E of 11.6; the median of its peer set is 14.7. A P/E above or below the median is a description, not a judgement on value.
Coral Laboratories' return on capital employed is 11.1%, above the peer median of 11.0%.